In contrast, low-avidity T cells were shown to upregulate members of the apoptosis pathway (e.g., Bim, FasL, and CD24) promoting their own cell death but also that of other tumor-specific T cells in the tumor microenvironment (173, 174). Here, BCL2L11 is linked to neoplasm.